Canada Pulls Controversial Pricing Measures
Executive Summary
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
You may also be interested in...
'Status Quo' Interim Pricing Guidance Now In Force In Canada
Provisional guidance on controversial pricing reforms is now in place in Canada.
Canada Says Reference Price Changes Could Save Payers Billions
Changes to Canada’s reference pricing system kick in on 1 July and could save billions.
What’s Next? Five Things To Look Out For In July
This month, long-awaited new pricing measures in Canada will come into force, while several trials will either kick off or end, including a liability opioids case involving Teva in San Francisco and Hatch-Waxman litigation over Otsuka/Lundbeck’s Rexulti.